734 related articles for article (PubMed ID: 31181979)
21. Gender Differences in Anemia and Survival in Patients Hospitalized for Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction.
Kajimoto K; Minami Y; Sato N; Otsubo S; Kasanuki H;
Am J Cardiol; 2017 Aug; 120(3):435-442. PubMed ID: 28583679
[TBL] [Abstract][Full Text] [Related]
22. Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum.
Lund LH; Claggett B; Liu J; Lam CS; Jhund PS; Rosano GM; Swedberg K; Yusuf S; Granger CB; Pfeffer MA; McMurray JJV; Solomon SD
Eur J Heart Fail; 2018 Aug; 20(8):1230-1239. PubMed ID: 29431256
[TBL] [Abstract][Full Text] [Related]
23. The subclinical hypothyroid state might predict 30-day readmission in patients admitted with acute heart failure syndrome and reduced left ventricular ejection fraction.
Saad M; Lacoste AG; Balar P; Zhang A; Vittorio TJ
Ther Adv Cardiovasc Dis; 2020; 14():1753944720977742. PubMed ID: 33336627
[TBL] [Abstract][Full Text] [Related]
24. Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes.
Shah KS; Xu H; Matsouaka RA; Bhatt DL; Heidenreich PA; Hernandez AF; Devore AD; Yancy CW; Fonarow GC
J Am Coll Cardiol; 2017 Nov; 70(20):2476-2486. PubMed ID: 29141781
[TBL] [Abstract][Full Text] [Related]
25. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.
Vicent L; Cinca J; Vazquez-García R; Gonzalez-Juanatey JR; Rivera M; Segovia J; Pascual-Figal D; Bover R; Worner F; Delgado-Jiménez J; Fernández-Avilés F; Martínez-Sellés M
Intern Med J; 2019 Dec; 49(12):1505-1513. PubMed ID: 30887642
[TBL] [Abstract][Full Text] [Related]
26. Right Atrial Phasic Function in Heart Failure With Preserved and Reduced Ejection Fraction.
Jain S; Kuriakose D; Edelstein I; Ansari B; Oldland G; Gaddam S; Javaid K; Manaktala P; Lee J; Miller R; Akers SR; Chirinos JA
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 1):1460-1470. PubMed ID: 30343071
[TBL] [Abstract][Full Text] [Related]
27. Functional mitral regurgitation at discharge and outcomes in patients hospitalized for acute decompensated heart failure with a preserved or reduced ejection fraction.
Kajimoto K; Sato N; Takano T;
Eur J Heart Fail; 2016 Aug; 18(8):1051-9. PubMed ID: 27212582
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
Chioncel O; Lainscak M; Seferovic PM; Anker SD; Crespo-Leiro MG; Harjola VP; Parissis J; Laroche C; Piepoli MF; Fonseca C; Mebazaa A; Lund L; Ambrosio GA; Coats AJ; Ferrari R; Ruschitzka F; Maggioni AP; Filippatos G
Eur J Heart Fail; 2017 Dec; 19(12):1574-1585. PubMed ID: 28386917
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for rehospitalization in heart failure with preserved ejection fraction compared with reduced ejection fraction.
Setoguchi M; Hashimoto Y; Sasaoka T; Ashikaga T; Isobe M
Heart Vessels; 2015 Sep; 30(5):595-603. PubMed ID: 24935218
[TBL] [Abstract][Full Text] [Related]
30. Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target.
Manolis AS; Manolis AA; Manolis TA; Melita H
Heart Fail Rev; 2019 Nov; 24(6):847-866. PubMed ID: 31147814
[TBL] [Abstract][Full Text] [Related]
31. In-hospital mortality and prognostic factors in patients admitted for new-onset heart failure with preserved or reduced ejection fraction: a prospective observational study.
Tribouilloy C; Rusinaru D; Leborgne L; Mahjoub H; Szymanski C; Houpe D; Béguin M; Peltier M
Arch Cardiovasc Dis; 2008 Apr; 101(4):226-34. PubMed ID: 18654097
[TBL] [Abstract][Full Text] [Related]
32. The partnership between renalase and ejection fraction as a risk factor for increased cardiac remodeling biomarkers in chronic heart failure patients.
Stojanovic D; Mitic V; Stojanovic M; Petrovic D; Ignjatovic A; Stefanovic N; Cvetkovic T; Kocic G; Bojanic V; Deljanin Ilic M
Curr Med Res Opin; 2020 Jun; 36(6):909-919. PubMed ID: 32297799
[No Abstract] [Full Text] [Related]
33. Effective blood hemoglobin level to predict prognosis in heart failure with preserved left ventricular ejection fraction: results of the Japanese heart failure syndrome with preserved ejection fraction registry.
Okuno K; Naito Y; Asakura M; Sugahara M; Ando T; Yasumura S; Nagai T; Saito Y; Yoshikawa T; Masuyama T; Anzai T
Heart Vessels; 2019 Jul; 34(7):1168-1177. PubMed ID: 30675647
[TBL] [Abstract][Full Text] [Related]
34. Regional Variation of Mortality in Heart Failure With Reduced and Preserved Ejection Fraction Across Asia: Outcomes in the ASIAN-HF Registry.
MacDonald MR; Tay WT; Teng TK; Anand I; Ling LH; Yap J; Tromp J; Wander GS; Naik A; Ngarmukos T; Siswanto BB; Hung CL; Richards AM; Lam CSP; ;
J Am Heart Assoc; 2020 Jan; 9(1):e012199. PubMed ID: 31852421
[TBL] [Abstract][Full Text] [Related]
35. Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction.
Kanagala P; Arnold JR; Cheng ASH; Singh A; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
Int J Cardiovasc Imaging; 2020 Jan; 36(1):101-110. PubMed ID: 31401742
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction - A report from the JASPER registry.
Sato Y; Yoshihisa A; Oikawa M; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T
J Cardiol; 2019 Jun; 73(6):459-465. PubMed ID: 30718015
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Value of Minimal Left Atrial Volume in Heart Failure With Preserved Ejection Fraction.
Shin SH; Claggett B; Inciardi RM; Santos ABS; Shah SJ; Zile MR; Pfeffer MA; Shah AM; Solomon SD
J Am Heart Assoc; 2021 Aug; 10(15):e019545. PubMed ID: 34325519
[TBL] [Abstract][Full Text] [Related]
38. Long-term and clinical profile of heart failure with recovered ejection fraction in a non-tertiary hospital.
Martínez-Mateo V; Fernández-Anguita M; Cejudo L; Martín-Barrios E; Paule AJ
Med Clin (Barc); 2019 Jan; 152(2):50-54. PubMed ID: 29884453
[TBL] [Abstract][Full Text] [Related]
39. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction.
Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM
Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609
[TBL] [Abstract][Full Text] [Related]
40. Limited value of NT-proBNP as a prognostic marker of all-cause mortality in patients with heart failure with preserved and mid-range ejection fraction in primary care: A report from the swedish heart failure register.
Eriksson B; Wändell P; Dahlström U; Näsman P; Lund LH; Edner M
Scand J Prim Health Care; 2019 Dec; 37(4):434-443. PubMed ID: 31724475
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
